PPT-HIV Testing www.hivguidelines.org

MAY 2022 NYSDOH AIDS Institute Clinical Guidelines Program A New HIV Diagnosis is a Call to Action In support of the NYSDOH AI January 2018 call to action for patients newly diagnosed with HIV the Medical Care Criteria Committee stresses the following. of ARVs for treatment and prevention. Getting to 15 million by 2015… . and thinking beyond. Gottfried Hirnschall MD, MPH. Department of HIV/AIDS, World Health Organization. July 26, 2012. Questions for today. Modular construcx00740069 on and versax00740069 lityTHREE in 1 scanner Possibility to rebuild to several versionsstability for high quality scans Applicax00740069 on with one two PA or TOFD pro The Desired Brand Effect Stand Out in a Saturated Market with a Timeless Brand The Desired Brand Effect Stand Out in a Saturated Market with a Timeless Brand www.hivguidelines.org. MARCH 2022. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Assist clinicians in recognizing common clinical manifestations of . M. genitalium. infection.. www.hivguidelines.org. NOVEMBER 2022. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. The purpose is to promote universal HIV screening in pregnancy to ensure timely diagnosis of HIV and rapid initiation of ART, which can prevent perinatal transmission and protect the health of patients and their infants. To meet these goals, this guideline emphasizes the following:. www.hivguidelines.org. JULY 2021. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Recognize the risks for and signs and symptoms of acute HIV, include HIV infection in the differential diagnosis, and consider HIV testing in any person who presents with signs and symptoms suggestive of influenza (“flu”), mononucleosis (“mono”), or other viral syndromes, including suspected COVID-19.. APRIL 2021. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Raise awareness among healthcare providers about IRIS, including its clinical presentation.. Provide treatment recommendations for IRIS.. www.hivguidelines.org. JANUARY 2021. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Increase the number of clinicians in outpatient settings offering evidence-based treatment to individuals with opioid use disorder.. FEBRUARY 2023. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Provides guidance for choosing safe and efficacious ART regimens based on known patient characteristics, before results of recommended resistance testing or baseline laboratory testing are available.. and. HIV Resistance Assays. www.hivguidelines.org. JUNE 2023. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of These Guidelines. Virologic and Immunologic Monitoring in HIV Care. Guide clinicians in the use of HIV viral load testing at appropriate times and intervals to assess initial and ongoing ART responses. www.hivguidelines.org. JANUARY 2023. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Increase compliance with the 2014 New York State public health law that requires that an HCV screening test be offered to every individual born between 1945 and 1965 who receives healthcare services from a physician, physician assistant, or nurse practitioner in a primary care or inpatient hospital setting.. www.hivguidelines.org. MAY 2024. NYSDOH AIDS Institute Clinical Guidelines Program. Terminology. In November 2022, the CDC aligned its terminology with that of the WHO and adopted the term mpox to refer to monkeypox, to reduce negative effects, including stigma, associated with the use of the term monkeypox. Mpox refers to the disease caused by infection with the human monkeypox virus (MPXV), a member of the . www.hivguidelines.org. MAY 2024. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guidance. Inform New York State clinicians who provide primary care to adolescents about existing regulations that allow minors (<18 years old) to consent for and receive confidential HIV and STI screening and treatment and biomedical HIV prevention in the form of pre- or post-exposure prophylaxis (.